Enamel Matrix Proteins in the Treatment of Intrabony Defects in Patients With Aggressive and Chronic Periodontitis

PHASE4CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

April 30, 2018

Study Completion Date

April 30, 2018

Conditions
Aggressive Periodontitis
Interventions
BIOLOGICAL

Enamel Matrix Proteins

EMD is composed of different proteins, 90% of which are amelogenins, which has the capacity to induce processes involved in the regeneration of periodontal tissues in a manner similar to normal tissue development (48). Several clinical and animal model studies have demonstrated the use of enamel matrix-derived proteins in regenerative periodontal procedures for the formation of a new periodontium.

PROCEDURE

Open Flap Debridement

After administration of local anesthetics, full-thickness flaps will be raised in order to access all defect faces. Sulcular incisions will be performed extending to mesial and distal adjacent teeth, including the entire papilla in the flap. No relaxing incisions will be performed. All granulation tissue will then be carefully removed, and subsequently scaling and root planing will be performed. The surgical area will be irrigated with 0.9% saline and carefully inspected to ensure that all steps have been satisfactorily performed until then.

Trial Locations (1)

13414-903

Piracicaba Dental School, State University of Campinas, Piracicaba

All Listed Sponsors
lead

University of Campinas, Brazil

OTHER

NCT03025204 - Enamel Matrix Proteins in the Treatment of Intrabony Defects in Patients With Aggressive and Chronic Periodontitis | Biotech Hunter | Biotech Hunter